SS
ATOS icon

SBI Securities’s Atossa Therapeutics ATOS Stock Holding History

SBI Securities’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286 Buy
148
+35
+31% +$160 ﹤0.01% 3211
2026
Q1 		$594 Buy
113
+9
+9% +$57 ﹤0.01% 2823
2025
Q4 		$923 Hold
104
– – ﹤0.01% 2674
2025
Q3 		$1.36K Hold
104
– – ﹤0.01% 2572
2025
Q2 		$1.3K Sell
104
-1
-1% -$12 ﹤0.01% 2563
2025
Q1 		$1.06K Buy
105
+1
+1% +$12 ﹤0.01% 2555
2024
Q4 		$1.48K Buy
+104
New +$2.03K ﹤0.01% 2427

Other funds holding ATOS

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SBI Securities's ATOS Position: Q2 2026 in Review

SBI Securities increased its Atossa Therapeutics (ATOS) stake by 31% in Q2 2026, buying an estimated $160 and bringing the position to 148 shares worth $286. The position accounts for ﹤0.01% of the portfolio, ranked #3211.

SBI Securities first reported a position in ATOS in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.48K in Q4 2024. 31 funds tracked by Wall St. Rank hold ATOS as of Q2 2026.

  • SBI Securities held 148 shares of Atossa Therapeutics worth $286 as of Q2 2026.
  • SBI Securities bought 35 Atossa Therapeutics shares in Q2 2026, an estimated $160.
  • Atossa Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3211 holding.
  • SBI Securities first reported a position in Atossa Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Atossa Therapeutics position peaked at $1.48K in Q4 2024.
  • 31 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.